Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)

1.245 -0.005 (-0.40%)

Delayed Quote Updated: 9:34 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Allogene Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data in an Oral Presentation at the International Conference on Malignant Lymphoma (ICML) Lugano

June 15, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Why Allogene Stock Is Trading Down Today ↗

June 14, 2023

Allogene Therapeutics, Inc. (NASDAQ: ALLO) shares are trading lower after the company announced its CFO Eric Schmidt will step down from his position.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 14, 2023

Via Benzinga

Allogene Therapeutics Announces Departure of Chief Financial Officer

June 14, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Where Allogene Therapeutics Stands With Analysts ↗

May 26, 2023

Via Benzinga

The Latest Analyst Ratings for Allogene Therapeutics ↗

May 04, 2023

Via Benzinga

Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 14, 2023

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...

Via Benzinga

Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano

June 09, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Recap: Allogene Therapeutics Q1 Earnings ↗

May 03, 2023

Via Benzinga

Where Allogene Therapeutics Stands With Analysts ↗

April 18, 2023

Via Benzinga

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

June 03, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences

May 24, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

The 3 Best Stocks to Short in May 2023 ↗

May 19, 2023

The best stocks to short are companies whose businesses aren’t faring well and have a higher-than-average short interest.

Via InvestorPlace

7 Short-Interest Stocks to Target for Explosive Gains ↗

May 18, 2023

For contrarian investors that can stand the heat, short-interest stocks to buy can offer significant rewards in a short time period.

Via InvestorPlace

As Feinstein Returns To Congress, Reports Of Her Stock Profits Upset Aaron Rodgers ↗

May 15, 2023

Sen. Dianne Feinstein of California, one of the wealthiest members of Congress, continues to draw ire for her questionable stock trading while in office. What Happened: Feinstein, 89, "has some of the...

Via Benzinga

Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress

May 11, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday ↗

May 04, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 04, 2023

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.

Via Benzinga

Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update

May 03, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Announces Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

April 26, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday ↗

April 25, 2023

U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Allogene Therapeutics to Report First Quarter 2023 Financial Results on May 3, 2023

April 25, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Appoints Timothy Moore as Chief Technical Officer

April 20, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Presents Interim Phase 1 Data on ALLO-316 in Renal Cell Carcinoma at the American Association of Cancer Research (AACR) Annual Meeting

April 17, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

7 Short-Squeeze Stocks That Could Make You Rich ↗

April 13, 2023

Although moving against the grain presents its own distinct set of risks, these short-squeeze stocks may profit the contrarian.

Via InvestorPlace

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 13, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences

April 13, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

7 Short-Squeeze Stocks That Could Explode in April ↗

March 30, 2023

Although these short-squeeze stocks attracted bearish attention justifiably, contrarian sentiment may see them jump higher.

Via InvestorPlace

Allogene Therapeutics Publishes 2022 Annual Environmental, Social and Governance (ESG) Report

March 30, 2023

Report Highlights Company’s Mission to Democratize Patient Access to CAR T While Maintaining Focus on Employee Engagement, Sustainability and Corporate Governance

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Short Interest Update - Monday, March 27 ↗

March 27, 2023

Although equities broadly are starting the new week higher, the most heavily shorted stocks are trading lower today.

Via Talk Markets

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.